why is tirzepatide no longer available 🚨 Important Update on Access! 🚨 Due to new regulations, most compounding pharmacies will be able to produce tirzepatide after February 18th. This may impact those who rely on Mounjaro for weight loss approved

Manufacturing peptides at pharmaceutical scale is technically challenging

Headache : This is another common side effect, particularly during the initial weeks of treatment

Furthermore, this higher-dose formulation makes T40mg particularly suitable for extended preclinical studies requiring greater compound availability

Taken together, the available evidence supports Mounjaro as a cardiovascularly safe option for people with type 2 diabetes and established heart disease, offering powerful glucose lowering and weight reduction while matching the cardiovascular protection seen with established GLP-1 therapies

It is billed monthly and is separate from your medication cost